Ectopic expression of CCRK in immortalized human liver cells activated β-catenin/TCF signaling to stimulate cell cycle progression and to induce tumor formation, as shown in both xenograft and orthotopic models.
Knockdown of CCRK decreased HCC cell growth, and this could be rescued by constitutively active β-catenin or TCF.